Quick Answer
Tectonic Therapeutic, Inc. reported Diluted EPS of $4.05 per share (loss) for fiscal year 2025.
Tectonic Therapeutic, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$4.05 | +40.7% |
| 2024 | -$6.83 | +79.8% |
| 2023 | -$33.76 | -1295.0% |
| 2022 | -$2.42 | +12.9% |
| 2021 | -$2.78 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.02 | +15.0% | +4.7% |
| June 30, 2025 | -$1.07 | +75.3% | -15.1% |
| March 31, 2025 | -$0.93 | +91.5% | +22.5% |
| September 30, 2024 | -$1.20 | +84.3% | +72.4% |
| June 30, 2024 | -$4.34 | +49.0% | +60.4% |
| March 31, 2024 | -$10.97 | -1824.6% | -44.0% |
| September 30, 2023 | -$7.62 | -1365.4% | +10.5% |
| June 30, 2023 | -$8.51 | -1229.7% | -1393.0% |
- Tectonic Therapeutic, Inc. showed an increase of +40.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Tectonic Therapeutic, Inc.’s diluted eps has declined by 45.7% (from $2.78 per share (loss) to $4.05 per share (loss)).
- The most recent figure is from Tectonic Therapeutic, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: